AnaptysBio, Inc is a biotechnology business based in the US. AnaptysBio shares (ANAB) are listed on the NASDAQ and all prices are listed in US Dollars. AnaptysBio employs 94 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in AnaptysBio
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ANAB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
AnaptysBio stock price (NASDAQ: ANAB)Use our graph to track the performance of ANAB stocks over time.
AnaptysBio shares at a glance
|Latest market close||$23.87|
|52-week range||$13.92 - $35.86|
|50-day moving average||$25.18|
|200-day moving average||$24.73|
|Wall St. target price||$33.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.01|
Buy AnaptysBio shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy AnaptysBio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
AnaptysBio price performance over time
|1 week (2021-07-18)||N/A|
|1 month (2021-06-29)||-7.08%|
|3 months (2021-04-29)||-2.09%|
|6 months (2021-01-25)||N/A|
|1 year (2020-07-25)||N/A|
|2 years (2019-07-25)||N/A|
|3 years (2018-07-25)||N/A|
|5 years (2016-07-25)||N/A|
|Revenue TTM||$71.2 million|
|Gross profit TTM||$-5,025,000|
|Return on assets TTM||-4.87%|
|Return on equity TTM||-7.63%|
|Market capitalisation||$706.4 million|
TTM: trailing 12 months
Shorting AnaptysBio shares
There are currently 3.1 million AnaptysBio shares held short by investors – that's known as AnaptysBio's "short interest". This figure is 18.2% down from 3.8 million last month.
There are a few different ways that this level of interest in shorting AnaptysBio shares can be evaluated.
AnaptysBio's "short interest ratio" (SIR)
AnaptysBio's "short interest ratio" (SIR) is the quantity of AnaptysBio shares currently shorted divided by the average quantity of AnaptysBio shares traded daily (recently around 289787.76844071). AnaptysBio's SIR currently stands at 10.71. In other words for every 100,000 AnaptysBio shares traded daily on the market, roughly 10710 shares are currently held short.
However AnaptysBio's short interest can also be evaluated against the total number of AnaptysBio shares, or, against the total number of tradable AnaptysBio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AnaptysBio's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 AnaptysBio shares in existence, roughly 110 shares are currently held short) or 0.1825% of the tradable shares (for every 100,000 tradable AnaptysBio shares, roughly 183 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against AnaptysBio.
Find out more about how you can short AnaptysBio stock.
AnaptysBio share dividends
We're not expecting AnaptysBio to pay a dividend over the next 12 months.
AnaptysBio share price volatility
Over the last 12 months, AnaptysBio's shares have ranged in value from as little as $13.92 up to $35.855. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AnaptysBio's is 0.0683. This would suggest that AnaptysBio's shares are less volatile than average (for this exchange).
AnaptysBio, Inc. , a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. The company's products include Imsidolimab, an IL-36R antibody that inhibits the interleukin-36 receptor for the treatment of various dermatological inflammatory diseases; ANB030, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through ANB030 treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. It also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. AnaptysBio, Inc. has a collaboration and license agreement with TESARO, Inc. and Celgene Corporation; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation.
Stocks similar to AnaptysBio
AnaptysBio in the news
Hedge Funds Cashed Out Of AnaptysBio, Inc. (ANAB) Too Early
AnaptysBio Breaks Below 200-Day Moving Average - Notable for ANAB
AnaptysBio up 7% after blog repot claims takeover approach received
Frequently asked questionsWhat percentage of AnaptysBio is owned by insiders or institutions?
Currently 0.556% of AnaptysBio shares are held by insiders and 113.777% by institutions. How many people work for AnaptysBio?
Latest data suggests 94 work at AnaptysBio. When does the fiscal year end for AnaptysBio?
AnaptysBio's fiscal year ends in December. Where is AnaptysBio based?
AnaptysBio's address is: 10421 Pacific Center Court, San Diego, CA, United States, 92121 What is AnaptysBio's ISIN number?
AnaptysBio's international securities identification number is: US0327241065 What is AnaptysBio's CUSIP number?
AnaptysBio's Committee on Uniform Securities Identification Procedures number is: 032724106
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert